JP2024544499A5 - - Google Patents
Info
- Publication number
- JP2024544499A5 JP2024544499A5 JP2024526888A JP2024526888A JP2024544499A5 JP 2024544499 A5 JP2024544499 A5 JP 2024544499A5 JP 2024526888 A JP2024526888 A JP 2024526888A JP 2024526888 A JP2024526888 A JP 2024526888A JP 2024544499 A5 JP2024544499 A5 JP 2024544499A5
- Authority
- JP
- Japan
- Prior art keywords
- hfviii
- genetically modified
- polypeptide according
- substituted amino
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021133004 | 2021-11-25 | ||
| CNPCT/CN2021/133004 | 2021-11-25 | ||
| PCT/CN2022/075976 WO2023092864A1 (en) | 2021-11-25 | 2022-02-11 | Engineered human fviii with enhanced secretion ability and clotting activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024544499A JP2024544499A (ja) | 2024-12-03 |
| JP2024544499A5 true JP2024544499A5 (cg-RX-API-DMAC7.html) | 2025-02-10 |
Family
ID=84487686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526888A Pending JP2024544499A (ja) | 2021-11-25 | 2022-02-11 | 遺伝子工学的改変により得られた、分泌能と凝固活性を向上させた組換えヒト第viii因子 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240254197A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4211153A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024544499A (cg-RX-API-DMAC7.html) |
| CN (3) | CN118638211A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023092864A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1502921A1 (en) * | 2003-07-29 | 2005-02-02 | ZLB Behring GmbH | Recombinant mutated human factor VIII (FVIII) with improved stability |
| EP1985631A1 (en) * | 2007-04-20 | 2008-10-29 | LFB Biotechnologies | Demannosylated recombinant factor VIII for the treatment of patients with hemophiila A |
| WO2013123457A1 (en) * | 2012-02-15 | 2013-08-22 | Biogen Idec Ma Inc. | Recombinant factor viii proteins |
| HRP20210031T1 (hr) * | 2013-06-24 | 2021-05-14 | Weidong, Xiao | Pripravci i metode mutantskog faktora viii |
| US20160311885A1 (en) * | 2013-08-14 | 2016-10-27 | Biogen Ma Inc. | Recombinant factor viii proteins |
| ES2819123T3 (es) * | 2015-01-30 | 2021-04-15 | Univ Emory | Proteínas del factor VIII que tienen secuencias ancestrales, vectores de expresión, y usos relacionados con ellos |
| CN108884145B (zh) * | 2015-11-13 | 2023-08-22 | 武田药品工业株式会社 | 用于血友病a的基因治疗的具有增加的表达的编码重组fviii变体的病毒载体 |
| KR102219859B1 (ko) * | 2016-06-24 | 2021-02-25 | 재단법인 목암생명과학연구소 | 재조합 단쇄 fviii 및 그 화학 접합물 |
| JP2020519272A (ja) * | 2017-05-09 | 2020-07-02 | エモリー ユニバーシティー | 凝固因子変異体及びその使用 |
| TWI851647B (zh) * | 2019-01-16 | 2024-08-11 | 日商武田藥品工業股份有限公司 | 用於a型血友病基因治療之編碼表現增加之重組fviii變異體的病毒載體 |
| WO2022165390A1 (en) * | 2021-01-29 | 2022-08-04 | Expression Therapeutics, Llc | Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
-
2022
- 2022-02-11 CN CN202410604831.3A patent/CN118638211A/zh active Pending
- 2022-02-11 EP EP22726380.3A patent/EP4211153A4/en active Pending
- 2022-02-11 WO PCT/CN2022/075976 patent/WO2023092864A1/en not_active Ceased
- 2022-02-11 US US17/774,450 patent/US20240254197A1/en active Pending
- 2022-02-11 JP JP2024526888A patent/JP2024544499A/ja active Pending
- 2022-02-11 CN CN202410604829.6A patent/CN118546234A/zh active Pending
- 2022-02-11 CN CN202280001407.9A patent/CN116710554B/zh active Active